| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
92,433 |
80,461 |
$5.31M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
11,119 |
10,676 |
$2.50M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,446 |
14,482 |
$2.16M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
5,292 |
5,128 |
$1.71M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,692 |
20,427 |
$1.62M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,311 |
11,014 |
$1.62M |
| 93975 |
|
6,652 |
6,410 |
$1.52M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,428 |
16,534 |
$1.50M |
| 80053 |
Comprehensive metabolic panel |
93,506 |
83,631 |
$1.18M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12,820 |
12,241 |
$1.14M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,255 |
17,655 |
$1.14M |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,347 |
9,009 |
$1.11M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
41,607 |
37,938 |
$1.09M |
| 0122 |
|
155 |
151 |
$849K |
| 0259 |
|
40,612 |
36,230 |
$820K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
108,295 |
95,017 |
$773K |
| 99499 |
|
9,036 |
7,315 |
$744K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,949 |
19,434 |
$696K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,054 |
15,793 |
$693K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,773 |
6,423 |
$555K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18,581 |
17,124 |
$544K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,653 |
4,500 |
$525K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,862 |
2,788 |
$500K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
7,895 |
7,526 |
$499K |
| 0121 |
|
56 |
56 |
$434K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,071 |
1,991 |
$403K |
| J3490 |
Unclassified drugs |
59,527 |
33,974 |
$359K |
| 71046 |
Radiologic examination, chest; 2 views |
16,200 |
15,514 |
$342K |
| 84443 |
Thyroid stimulating hormone (TSH) |
19,985 |
19,516 |
$332K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,137 |
4,874 |
$316K |
| 71045 |
Radiologic examination, chest; single view |
27,374 |
25,620 |
$306K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,674 |
1,647 |
$302K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
22,926 |
20,503 |
$302K |
| 81001 |
|
34,753 |
32,398 |
$294K |
| 0250 |
|
14,075 |
10,601 |
$283K |
| 0762 |
|
421 |
381 |
$277K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,914 |
2,907 |
$271K |
| 93970 |
|
1,456 |
1,392 |
$268K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,619 |
8,543 |
$248K |
| 84484 |
|
27,968 |
24,464 |
$234K |
| 83690 |
|
33,140 |
30,210 |
$230K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,314 |
1,798 |
$214K |
| 0761 |
|
4,931 |
3,633 |
$212K |
| 80061 |
Lipid panel |
19,088 |
18,870 |
$203K |
| 76801 |
|
3,041 |
2,514 |
$202K |
| 87486 |
|
5,295 |
5,131 |
$201K |
| Z7502 |
|
6,039 |
5,827 |
$196K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,822 |
1,738 |
$190K |
| 76830 |
Ultrasound, transvaginal |
2,659 |
2,619 |
$189K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,470 |
2,295 |
$184K |
| 87581 |
|
5,297 |
5,131 |
$184K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,307 |
2,273 |
$173K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,780 |
2,687 |
$173K |
| 76770 |
|
2,271 |
2,221 |
$170K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17,329 |
17,128 |
$168K |
| 84480 |
|
10,591 |
10,430 |
$156K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
22,512 |
20,816 |
$144K |
| 76641 |
|
1,962 |
1,856 |
$143K |
| 93971 |
|
1,236 |
1,211 |
$141K |
| 83880 |
|
5,225 |
4,833 |
$138K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,957 |
2,315 |
$137K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
17,845 |
16,709 |
$130K |
| 36902 |
|
1,162 |
1,152 |
$128K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,410 |
11,399 |
$124K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
548 |
525 |
$119K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,424 |
2,343 |
$117K |
| 59025 |
Fetal non-stress test |
3,547 |
1,614 |
$116K |
| 93000 |
|
2,912 |
2,859 |
$115K |
| 84439 |
|
12,466 |
12,254 |
$114K |
| 73630 |
|
3,934 |
3,806 |
$113K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,052 |
889 |
$107K |
| 73562 |
|
3,705 |
3,604 |
$106K |
| 73130 |
|
2,995 |
2,893 |
$100K |
| 70486 |
|
644 |
622 |
$99K |
| 81025 |
|
9,170 |
8,542 |
$97K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
376 |
369 |
$97K |
| Z9725 |
|
3,212 |
3,185 |
$96K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,516 |
1,382 |
$95K |
| 0636 |
|
10,734 |
9,977 |
$93K |
| 0171 |
Inj, epinephrine (belcher) |
64 |
64 |
$93K |
| 73610 |
|
3,081 |
2,983 |
$91K |
| G0378 |
Hospital observation service, per hour |
2,687 |
2,058 |
$91K |
| 73030 |
|
3,019 |
2,933 |
$86K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,313 |
12,823 |
$84K |
| 83605 |
|
7,456 |
6,665 |
$79K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,483 |
2,374 |
$76K |
| 82607 |
|
5,447 |
5,406 |
$73K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,799 |
2,792 |
$73K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,647 |
1,461 |
$72K |
| 82948 |
|
10,611 |
7,073 |
$70K |
| 97139 |
|
1,942 |
466 |
$69K |
| 72100 |
|
1,964 |
1,927 |
$68K |
| 87040 |
|
4,844 |
4,220 |
$68K |
| 36415 |
Collection of venous blood by venipuncture |
23,151 |
18,577 |
$66K |
| 73110 |
|
2,155 |
2,072 |
$66K |
| 0361 |
|
429 |
379 |
$64K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,325 |
6,465 |
$63K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,036 |
1,989 |
$63K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,462 |
2,114 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,234 |
1,184 |
$62K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,566 |
5,398 |
$61K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
1,233 |
1,204 |
$60K |
| 70496 |
|
337 |
336 |
$59K |
| 72110 |
|
1,263 |
1,251 |
$59K |
| 87507 |
|
146 |
143 |
$58K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,481 |
6,951 |
$58K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
324 |
321 |
$58K |
| 87186 |
|
6,573 |
6,219 |
$57K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,034 |
1,987 |
$56K |
| 70498 |
|
362 |
359 |
$55K |
| 85379 |
|
3,727 |
3,606 |
$54K |
| 96367 |
|
1,396 |
1,107 |
$53K |
| 86480 |
|
984 |
978 |
$50K |
| 93976 |
|
246 |
229 |
$50K |
| 86901 |
|
4,983 |
4,539 |
$49K |
| J7050 |
Infusion, normal saline solution, 250 cc |
7,323 |
5,270 |
$48K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,654 |
4,938 |
$46K |
| 73080 |
|
1,367 |
1,319 |
$44K |
| 86850 |
|
2,816 |
2,629 |
$43K |
| 90714 |
|
1,292 |
1,275 |
$43K |
| 76870 |
|
703 |
677 |
$41K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
881 |
860 |
$40K |
| 74018 |
|
1,644 |
1,600 |
$40K |
| 84702 |
|
2,597 |
2,143 |
$39K |
| 87077 |
|
5,698 |
5,468 |
$39K |
| 85730 |
|
6,906 |
6,458 |
$39K |
| 71250 |
|
311 |
310 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
868 |
856 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,349 |
3,279 |
$36K |
| 76604 |
|
778 |
735 |
$35K |
| 10060 |
|
803 |
740 |
$35K |
| 0710 |
|
1,565 |
1,477 |
$34K |
| 86140 |
|
6,581 |
6,225 |
$34K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,731 |
5,230 |
$34K |
| 80305 |
|
2,391 |
2,277 |
$34K |
| 82550 |
|
5,106 |
4,610 |
$34K |
| 72131 |
|
225 |
225 |
$33K |
| 99221 |
|
29 |
29 |
$33K |
| 77066 |
Tomosynthesis, mammo |
297 |
295 |
$33K |
| 85610 |
|
9,113 |
8,491 |
$32K |
| 73590 |
|
1,086 |
1,041 |
$32K |
| 86803 |
|
2,090 |
2,067 |
$31K |
| 82803 |
|
2,414 |
2,204 |
$31K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,192 |
1,159 |
$30K |
| 76775 |
|
731 |
702 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
914 |
872 |
$28K |
| 73090 |
|
849 |
830 |
$28K |
| 29125 |
|
670 |
647 |
$28K |
| 51701 |
|
589 |
567 |
$28K |
| 0272 |
|
2,139 |
2,044 |
$27K |
| 84153 |
|
1,603 |
1,585 |
$26K |
| 82728 |
|
2,333 |
2,302 |
$26K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,756 |
2,540 |
$25K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
113 |
96 |
$25K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
813 |
800 |
$25K |
| 84145 |
|
1,351 |
1,303 |
$23K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
833 |
791 |
$23K |
| 0270 |
|
2,081 |
1,966 |
$22K |
| 83735 |
|
3,692 |
2,985 |
$22K |
| A4217 |
Sterile water/saline, 500 ml |
1,560 |
1,322 |
$22K |
| 87451 |
|
3,269 |
3,114 |
$21K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,417 |
1,991 |
$21K |
| 11043 |
|
344 |
187 |
$20K |
| 87340 |
|
1,903 |
1,875 |
$20K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,063 |
2,831 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
840 |
627 |
$20K |
| 80076 |
|
2,808 |
2,706 |
$20K |
| 86701 |
|
1,363 |
1,341 |
$19K |
| 0258 |
|
603 |
485 |
$19K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
117 |
117 |
$19K |
| 84466 |
|
1,495 |
1,472 |
$18K |
| 82652 |
|
716 |
707 |
$18K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
39 |
24 |
$17K |
| 12001 |
|
251 |
247 |
$17K |
| 90715 |
|
438 |
426 |
$17K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,708 |
2,564 |
$16K |
| 81002 |
|
6,316 |
5,961 |
$16K |
| 0271 |
|
1,392 |
1,232 |
$16K |
| 73140 |
|
614 |
595 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
269 |
266 |
$16K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,262 |
1,219 |
$16K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
37 |
36 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,345 |
2,276 |
$15K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,090 |
993 |
$14K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
729 |
711 |
$14K |
| 80306 |
|
860 |
811 |
$14K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
89 |
89 |
$14K |
| 86705 |
|
1,126 |
1,114 |
$13K |
| 80074 |
|
213 |
211 |
$13K |
| 86709 |
|
1,118 |
1,107 |
$13K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,454 |
2,249 |
$12K |
| 85652 |
|
4,890 |
4,648 |
$12K |
| 83540 |
|
2,258 |
2,222 |
$12K |
| 99152 |
|
1,308 |
1,277 |
$12K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,440 |
831 |
$12K |
| 0750 |
|
81 |
79 |
$11K |
| 86308 |
|
1,232 |
1,206 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
196 |
193 |
$10K |
| 73503 |
|
246 |
242 |
$10K |
| 83655 |
|
1,123 |
1,119 |
$10K |
| 82570 |
|
2,515 |
2,304 |
$10K |
| 87205 |
|
2,569 |
2,351 |
$10K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,286 |
1,103 |
$10K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,787 |
2,595 |
$10K |
| 72040 |
|
283 |
276 |
$10K |
| 87070 |
|
1,254 |
1,166 |
$9K |
| 77080 |
|
326 |
322 |
$9K |
| 86900 |
|
3,159 |
2,955 |
$9K |
| A9270 |
Non-covered item or service |
3,057 |
2,251 |
$9K |
| 84550 |
|
2,270 |
2,087 |
$9K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
44 |
43 |
$9K |
| 76882 |
|
563 |
535 |
$9K |
| 97750 |
|
123 |
114 |
$9K |
| 84403 |
|
513 |
502 |
$9K |
| 86920 |
|
95 |
90 |
$8K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
24 |
24 |
$8K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,353 |
1,234 |
$8K |
| 86787 |
|
229 |
225 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
168 |
66 |
$8K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
687 |
609 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
27 |
27 |
$8K |
| 76881 |
|
151 |
151 |
$8K |
| 82553 |
|
682 |
599 |
$7K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,875 |
2,436 |
$7K |
| 0360 |
|
42 |
38 |
$7K |
| 84100 |
|
1,843 |
1,358 |
$7K |
| 86592 |
|
1,680 |
1,639 |
$7K |
| 76536 |
|
121 |
121 |
$7K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
499 |
382 |
$7K |
| 84703 |
|
738 |
674 |
$7K |
| 73564 |
|
198 |
196 |
$7K |
| 12011 |
|
80 |
77 |
$6K |
| 86677 |
|
387 |
377 |
$6K |
| Q3014 |
Telehealth originating site facility fee |
861 |
852 |
$6K |
| 72050 |
|
142 |
142 |
$6K |
| 82043 |
|
1,153 |
1,143 |
$6K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
196 |
126 |
$5K |
| Z7610 |
|
739 |
607 |
$5K |
| J1756 |
Injection, iron sucrose, 1 mg |
81 |
37 |
$5K |
| 52000 |
|
65 |
65 |
$5K |
| 86038 |
|
702 |
692 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
533 |
380 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
89 |
76 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
127 |
119 |
$5K |
| 29515 |
|
79 |
72 |
$5K |
| 72072 |
|
140 |
136 |
$5K |
| 84156 |
|
1,454 |
1,273 |
$4K |
| 82670 |
|
221 |
217 |
$4K |
| 83550 |
|
681 |
675 |
$4K |
| 83615 |
|
714 |
610 |
$4K |
| 0637 |
|
346 |
335 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
51 |
50 |
$4K |
| 29530 |
|
174 |
163 |
$4K |
| 73502 |
|
132 |
128 |
$4K |
| 82009 |
|
685 |
647 |
$4K |
| G9012 |
Other specified case management service not elsewhere classified |
50 |
44 |
$3K |
| 96376 |
|
1,074 |
938 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$3K |
| 36430 |
|
13 |
13 |
$3K |
| 82040 |
|
35 |
34 |
$3K |
| 85018 |
|
1,387 |
1,353 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
803 |
785 |
$3K |
| 85027 |
|
479 |
439 |
$3K |
| 74178 |
|
15 |
15 |
$3K |
| 85014 |
|
1,267 |
1,240 |
$3K |
| 70491 |
|
12 |
12 |
$3K |
| 84270 |
|
187 |
184 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
343 |
337 |
$3K |
| 86762 |
|
193 |
190 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
178 |
102 |
$3K |
| 93017 |
|
52 |
50 |
$3K |
| 29540 |
|
243 |
232 |
$3K |
| 87081 |
|
92 |
87 |
$2K |
| 99215 |
Prolong outpt/office vis |
28 |
28 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68 |
67 |
$2K |
| 77065 |
Tomosynthesis, mammo |
25 |
25 |
$2K |
| 77062 |
|
89 |
89 |
$2K |
| 29105 |
|
13 |
13 |
$2K |
| 83918 |
|
105 |
103 |
$2K |
| 73060 |
|
89 |
88 |
$2K |
| 87420 |
|
462 |
442 |
$2K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
111 |
92 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
223 |
185 |
$2K |
| 70360 |
|
52 |
44 |
$2K |
| 96368 |
|
86 |
78 |
$2K |
| 82140 |
|
133 |
119 |
$2K |
| J1790 |
Injection, droperidol, up to 5 mg |
218 |
206 |
$2K |
| J3360 |
Injection, diazepam, up to 5 mg |
86 |
82 |
$2K |
| 0300 |
|
588 |
443 |
$2K |
| 0274 |
|
145 |
144 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
226 |
133 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
339 |
336 |
$1K |
| 0370 |
|
151 |
146 |
$1K |
| 87045 |
|
142 |
141 |
$1K |
| 51702 |
|
14 |
14 |
$1K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
222 |
212 |
$1K |
| 83001 |
|
151 |
151 |
$1K |
| 73552 |
|
54 |
53 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
102 |
84 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
218 |
213 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
187 |
158 |
$1K |
| 86200 |
|
144 |
142 |
$1K |
| 87220 |
|
234 |
214 |
$1K |
| 80081 |
|
13 |
13 |
$1K |
| 80069 |
|
243 |
233 |
$984.60 |
| 82746 |
|
86 |
84 |
$930.77 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
89 |
51 |
$896.00 |
| 82247 |
|
161 |
111 |
$892.35 |
| 36600 |
|
53 |
50 |
$867.65 |
| 87210 |
|
225 |
209 |
$859.38 |
| 83002 |
|
93 |
93 |
$836.94 |
| 82010 |
|
96 |
89 |
$817.57 |
| 93880 |
|
13 |
13 |
$814.44 |
| 88304 |
|
76 |
66 |
$780.91 |
| 87015 |
|
110 |
110 |
$738.56 |
| 87899 |
|
133 |
128 |
$734.74 |
| 83525 |
|
76 |
76 |
$733.38 |
| 87075 |
|
134 |
123 |
$710.34 |
| 87450 |
|
129 |
128 |
$687.78 |
| J1630 |
Injection, haloperidol, up to 5 mg |
120 |
110 |
$642.26 |
| 82330 |
|
47 |
47 |
$637.91 |
| 83970 |
|
59 |
59 |
$631.57 |
| 73560 |
|
37 |
37 |
$631.14 |
| 87324 |
|
53 |
52 |
$536.78 |
| 74019 |
|
26 |
26 |
$533.13 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
85 |
84 |
$434.58 |
| 76857 |
|
12 |
12 |
$432.90 |
| 86430 |
|
71 |
71 |
$432.46 |
| 82150 |
|
63 |
59 |
$431.05 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
27 |
25 |
$414.50 |
| 87521 |
Neg quan hep c or qual rna |
13 |
13 |
$393.80 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
51 |
51 |
$393.19 |
| 83874 |
|
32 |
28 |
$379.23 |
| 96523 |
|
49 |
43 |
$375.87 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
269 |
258 |
$372.65 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
787 |
775 |
$315.46 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
31 |
15 |
$305.09 |
| J7510 |
Prednisolone oral, per 5 mg |
63 |
63 |
$293.50 |
| 86738 |
|
19 |
19 |
$277.98 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
29 |
27 |
$265.91 |
| 84154 |
|
42 |
42 |
$261.00 |
| 73660 |
|
15 |
15 |
$257.58 |
| 17250 |
|
17 |
12 |
$246.20 |
| C1769 |
Guide wire |
536 |
513 |
$240.00 |
| 99153 |
Mod sedat endo service >5yrs |
100 |
99 |
$231.78 |
| 83520 |
|
12 |
12 |
$212.63 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
36 |
36 |
$200.95 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
47 |
27 |
$192.72 |
| J1940 |
Injection, furosemide, up to 20 mg |
84 |
55 |
$190.72 |
| 86696 |
|
12 |
12 |
$164.04 |
| 86695 |
|
12 |
12 |
$164.04 |
| 72170 |
|
14 |
14 |
$161.66 |
| 76000 |
|
13 |
13 |
$139.56 |
| 80051 |
|
32 |
30 |
$130.88 |
| 0402 |
|
74 |
72 |
$130.47 |
| 82105 |
|
13 |
13 |
$129.90 |
| 86317 |
|
12 |
12 |
$126.01 |
| 82947 |
|
24 |
24 |
$112.08 |
| 82270 |
|
28 |
12 |
$94.31 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
12 |
12 |
$87.38 |
| 87147 |
|
15 |
15 |
$78.29 |
| J2060 |
Injection, lorazepam, 2 mg |
15 |
15 |
$75.86 |
| 81015 |
|
1,245 |
1,204 |
$70.60 |
| 0301 |
|
473 |
384 |
$63.06 |
| 82248 |
|
13 |
13 |
$54.82 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
12 |
12 |
$44.92 |
| 0306 |
|
245 |
229 |
$41.67 |
| 0730 |
|
71 |
69 |
$29.84 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
34 |
33 |
$21.04 |
| 0324 |
|
70 |
70 |
$18.13 |
| 80197 |
|
14 |
13 |
$16.48 |
| 0278 |
|
12 |
12 |
$14.34 |
| 0305 |
|
421 |
386 |
$11.24 |
| 85007 |
|
127 |
127 |
$0.00 |
| 0258R |
|
91 |
90 |
$0.00 |
| 0270R |
|
695 |
683 |
$0.00 |
| 0272R |
|
694 |
682 |
$0.00 |
| 0710R |
|
270 |
266 |
$0.00 |
| 0480 |
|
12 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
69 |
69 |
$0.00 |
| 0370R |
|
41 |
40 |
$0.00 |
| 0720 |
|
111 |
109 |
$0.00 |
| 0250R |
|
1,039 |
527 |
$0.00 |
| 80329 |
|
13 |
13 |
$0.00 |
| 80320 |
|
17 |
17 |
$0.00 |